A Real-world Study on Golidocitinib-based Therapeutic Regimens for the Treatment of Patients With Peripheral T-cell Lymphoma
Not yet recruitingOBSERVATIONAL
Enrollment
1,000
Participants
Timeline
Start Date
April 30, 2025
Primary Completion Date
December 31, 2026
Study Completion Date
December 31, 2027
Conditions
Peripheral T-cell Lymphoma (PTCL)
All Listed Sponsors
lead
Ruijin Hospital
OTHER
NCT06963632 - A Real-world Study on Golidocitinib-based Therapeutic Regimens for the Treatment of Patients With Peripheral T-cell Lymphoma | Biotech Hunter | Biotech Hunter